Results for “skin disorders”
Human Skin
** Human skin is the body’s largest organ, serving as a protective barrier, sensory interface, and regulator of temperature, fluid balance, and immune function. **CONTENT:** ## Overview Human skin, scientifically termed the **integumentary system**, covers an average adult surface area of about 1.5–2 m² and accounts for roughly 16 % of total body weight. It is a complex, multilayered structure composed of three primary layers—the **epidermis**, **dermis**, and **subcutaneous tissue (hypodermis)**—each with distinct cell types, extracellular matrices, and physiological roles. The epidermis, the outermost layer, consists mainly of keratinocytes that produce keratin, a tough protein that provides mechanical resilience and water‑tight sealing. Beneath it, the dermis houses collagen and elastin fibers, blood vessels, nerves, hair follicles, and sweat glands, enabling sensation, thermoregulation, and nutrient delivery. The hypodermis stores adipose tissue, cushions internal organs, and serves as an energy reserve. Beyond its structural functions, skin acts as a dynamic immunological organ. Langerhans cells in the epidermis and dermal dendritic cells constantly surveil for pathogens, initiating innate and adaptive immune responses. The skin also synthesizes **vitamin D** through ultraviolet‑B (UVB) radiation exposure, a critical step for calcium homeostasis and bone health. Its sensory receptors detect touch, pressure, temperature, and pain, providing essential feedback for protective reflexes and environmental interaction. ## History/Background The scientific study of skin dates back to ancient civilizations; Egyptian papyri (c. 1500 BCE) describe wound care and the use of ointments, while Hippocrates (460–370 BCE) noted the skin’s role in disease manifestation. In the 16th century, **Andreas Vesalius** provided detailed anatomical illustrations, yet the microscopic architecture remained obscure until the invention of the light microscope by **Antonie van Leeuwenhoek** in the 1670s. The 19th‑century work of **Robert Hooke** and **Camillo Golgi** revealed cellular structures, and **Karl Langer** (1861) described the characteristic “Langer’s lines” of skin tension, still used in surgical planning. A pivotal moment arrived in 1881 when **Friedrich Henle** identified the **stratum basale**, establishing the concept of continuous epidermal renewal. The 20th century saw the discovery of **melanocytes** (1884, **Charles S. Levaditi**) and the elucidation of the **melanin synthesis pathway**, linking skin pigmentation to UV protection. The development of **dermatopathology** as a specialty in the 1940s, along with advances in histochemistry and electron microscopy, enabled precise classification of skin diseases. More recently, the Human Cell Atlas project (2020‑2023) has mapped skin cell types at single‑cell resolution, opening new avenues for regenerative medicine and personalized dermatology. ## Key Information - **Layers & Cell Types:** Epidermis (keratinocytes, melanocytes, Langerhans cells, Merkel cells); Dermis (fibroblasts, macrophages, mast cells, endothelial cells); Hypodermis (adipocytes, fibroblasts). - **Barrier Functions:** Prevents pathogen entry, limits transepidermal water loss, and shields against UV radiation. - **Thermoregulation:** Sweat glands produce sweat; vasodilation/vasoconstriction of dermal vessels modulates heat loss. - **Sensory Role:** Meissner’s corpuscles (light touch), Pacinian corpuscles (deep pressure/vibration), Ruffini endings (stretch), and free nerve endings (pain, temperature). - **Healing Process:** Involves hemostasis, inflammation, proliferation (granulation tissue, re‑epithelialization), and remodeling (collagen maturation). Chronic wounds may require professional intervention. - **Common Disorders:** Acne vulgaris, atopic dermatitis, psoriasis, melanoma, basal cell carcinoma, and fungal infections. Early detection of suspicious lesions is critical; any new, changing, or bleeding mole warrants prompt dermatologic evaluation. - **Skin Aging:** Intrinsic aging (genetic, hormonal) leads to collagen loss and thinning; extrinsic aging (UV exposure, smoking) accelerates elastin degradation, producing wrinkles and lentigines. - **Protective Measures:** Daily broad‑spectrum sunscreen (SPF 30+), moisturization to maintain barrier lipids, and avoidance of excessive UV exposure reduce cancer risk and premature aging. **When to Seek Professional Care:** Persistent rashes, unexplained itching, rapidly spreading lesions, non‑healing wounds, or any skin change suggestive of malignancy should be evaluated by a qualified dermatologist promptly. ## Significance Human skin is not merely a protective covering; it is a vital organ that integrates structural, immunologic, endocrine, and sensory systems. Its health directly influences overall well‑being—compromised barrier function can lead to dehydration, infection, and systemic inflammation. Dermatological conditions affect up to 30 % of the global population, imposing substantial economic and psychosocial burdens. Advances in skin biology have propelled innovations such as **biologic therapies** for psoriasis, **immune checkpoint inhibitors** for melanoma, and **tissue‑engineered skin grafts** for burn victims. Moreover, the skin’s accessibility makes it an ideal site for transdermal drug delivery, vaccine patches, and wearable biosensors, shaping the future of personalized medicine. Understanding skin’s multifaceted roles underscores the importance of preventive skin care, early disease detection, and ongoing research. As the interface between the body and environment, the skin remains a frontline defender, a sensory gateway, and a window into systemic health. **INFOBOX:** - Name: Human Skin (Integumentary System) - Type: Organ (largest external organ) - Date: Evolutionarily present in vertebrates; modern scientific description refined from 16th century onward - Location: Covers the entire external surface of the human body - Known For: Protective barrier, sensory organ, thermoregulation, vitamin D synthesis, immune surveillance **TAGS:** anatomy, dermatology, physiology, immunology, skin disorders, wound healing, photobiology, public health
Health & MedicinePsoriasis
** Psoriasis is a chronic, non‑contagious autoimmune skin disorder that produces red, scaly plaques ranging from isolated patches to full‑body involvement. **CONTENT:** ## Overview Psoriasis is a long‑lasting autoimmune disease in which the immune system mistakenly accelerates the growth cycle of skin cells. Normally, epidermal cells mature over about a month; in psoriasis, this process is compressed to just three to four days, causing a buildup of immature cells that appear as **thick, silvery‑white scales** on a background of inflamed, reddish skin. The lesions can be **painful, itchy, and sometimes bleed** when scratched, and they may appear on the scalp, elbows, knees, lower back, and nails. While the condition is **non‑contagious**, its visibility can lead to significant psychosocial distress, affecting self‑esteem, work productivity, and quality of life. The disease exhibits a wide spectrum of severity. Some individuals experience **mild, localized plaques** that respond to over‑the‑counter moisturizers, whereas others develop **moderate to severe disease** that covers large body areas and may be associated with systemic inflammation. Psoriasis is also linked with comorbidities such as **psoriatic arthritis**, cardiovascular disease, metabolic syndrome, and depression. Because of these associations, psoriasis is increasingly viewed as a **systemic inflammatory disorder**, not merely a skin problem. A hallmark trigger is the **Koebner phenomenon**, where skin injury—such as a cut, scrape, or even a tattoo—induces new psoriatic plaques at the site of trauma. Other common triggers include infections (especially streptococcal throat infections), stress, smoking, alcohol, certain medications (e.g., beta‑blockers, lithium), and climate changes. Recognizing these factors helps patients and clinicians tailor lifestyle modifications alongside medical therapy. ## History/Background Descriptions of scaly skin eruptions date back to ancient Egypt (the Ebers Papyrus, c. 1550 BC) and classical Greek writings, where physicians noted “the disease of the king’s skin.” The term **psoriasis** derives from the Greek *psōr* (“itch”) and *‑iasis* (“condition”). In the 19th century, **Robert Willan** and **Robert Wood** classified skin diseases, distinguishing psoriasis from eczema. The autoimmune nature was not recognized until the mid‑20th century, when **M. M. Kelley** and colleagues demonstrated T‑cell involvement. The discovery of **TNF‑α** and interleukin‑17 pathways in the 1990s revolutionized treatment, leading to the first biologic agents (e.g., etanercept, 2003). The **Koebner phenomenon** was first described by **Heinrich Koebner** in 1876, emphasizing the role of skin injury in disease propagation. ## Key Information - **Epidemiology:** Affects ~2–3 % of the global population, with similar prevalence across genders and ethnicities. - **Pathophysiology:** Dysregulated **Th1/Th17** immune responses cause overproduction of cytokines (IL‑17, IL‑23, TNF‑α) that stimulate keratinocyte proliferation. - **Clinical Types:** Includes plaque psoriasis (most common), guttate, inverse, pustular, and erythrodermic forms. - **Diagnosis:** Primarily clinical; skin biopsy reserved for atypical presentations. The **Psoriasis Area and Severity Index (PASI)** quantifies disease burden. - **Treatment Spectrum:** - *Topical*: corticosteroids, vitamin D analogues, retinoids, coal tar. - *Phototherapy*: narrow‑band UVB, excimer laser. - *Systemic non‑biologic*: methotrexate, cyclosporine, acitretin. - *Biologic agents*: TNF inhibitors, IL‑12/23 inhibitors, IL‑17 inhibitors, IL‑23 inhibitors. - **Lifestyle Management:** Moisturizing, smoking cessation, weight control, stress reduction, and avoidance of known triggers. - **When to Seek Professional Care:** Immediate evaluation is warranted for sudden widespread redness (erythroderma), severe joint pain suggesting psoriatic arthritis, or if topical measures fail to control symptoms. Persistent lesions that bleed, develop infection, or cause significant emotional distress should also prompt a dermatologist visit. ## Significance Psoriasis is more than a cosmetic concern; it serves as a **model disease** for understanding autoimmunity and the skin‑immune axis. The development of targeted biologics has not only transformed psoriasis care but also paved the way for therapies in other inflammatory conditions, such as inflammatory bowel disease and rheumatoid arthritis. Economically, psoriasis imposes a substantial burden through direct medical costs and indirect losses from work absenteeism. Psychologically, the visible nature of lesions can lead to stigma, anxiety, and depression, underscoring the need for holistic management that includes mental‑health support. Ongoing research into the genetic basis (e.g., **HLA‑C*06:02**) and microbiome interactions promises to refine personalized treatment strategies, moving the field toward **precision dermatology**. **INFOBOX:** - Name: Psoriasis - Type: Chronic autoimmune skin disease - Date: First documented in ancient medical texts; modern classification established 19th century - Location: Worldwide; prevalence ~2–3 % of population - Known For: Red, scaly plaques; Koebner phenomenon; pioneering role in biologic therapy development **TAGS:** dermatology, autoimmune disease, skin disorders, chronic illness, biologic therapy, Koebner phenomenon, psoriatic arthritis, public health